Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative staging by nano-MRI (Combidex/ferumoxtran-10) in resectable esophageal cancer after neoadjuvant chemoradiotherapy
2016-003133-18Phase 2Completed
- Sponsor
- Radboudumc
- Start
- Nov 2016
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ferumoxtran-10 in esophageal cancer, sponsored by Radboudumc. Primary endpoint: Diagnostic accuracy of in-vivo nano-MRI. Started Nov 2016; status: completed.
02
Drugs
ferumoxtran-10
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on 2016-003133-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003133-18.